Who owns KAZIA THERAPEUTICS LTD SPONSORED ADS?
- Ticker: KZIA
- CUSIP Number: 48669g303
Tip: Access positions for across all investors
Analyze quarterly positions in Kazia Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Kazia Therapeutics stock
Who bought or sold KAZIA THERAPEUTICS LTD SPONSORED ADS this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Boxer Capital Management | 560k | $7.9M | 100% | Jun 2026 |
|
| Putnam Fl Investment Management | 415k | $5.8M | 191% | Jun 2026 |
|
| Bleichroeder | 400k | $5.6M | 0% | Jun 2026 |
|
| Ikarian Capital | 396k | $5.6M | 100% | Jun 2026 |
|
| Dauntless Investment Group | 354k | $5.0M | 344% | Jun 2026 |
|
| Stonepine Capital Management | 345k | $4.9M | 0% | Jun 2026 |
|
| Susquehanna International | 333k | $4.7M | 100% | Jun 2026 |
|
| Point72 Asset Management | 200k | $2.3M | 0% | Jun 2026 |
|
| Ensign Peak Advisors | 111k | $1.6M | 100% | Jun 2026 |
|
| Citadel Advisors | 105k | $1.5M | 100% | Jun 2026 |
|
| Millennium Management | 101k | $1.4M | 100% | Jun 2026 |
|
| Jane Street | 93k | $1.3M | 100% | Jun 2026 |
|
| UBS Group | 81k | $1.1M | 482% | Jun 2026 |
|
| J. Goldman & Co | 69k | $964k | 100% | Jun 2026 |
|
| ADAR1 Capital Management | 62k | $867k | 100% | Jun 2026 |
|
| Barclays | 61k | $585k | 7% | Sep 2026 |
|
| Steel Peak Wealth Management | 61k | $581k | 100% | Sep 2026 |
|
| Westside Investment Management | 57k | $545k | 19% | Sep 2026 |
|
| Omega Advisors | 50k | $704k | 100% | Jun 2026 |
|
| Marshall Wace | 44k | $623k | 100% | Jun 2026 |
|
| ACT Capital Partners | 35k | $336k | 100% | Sep 2026 |
|
| XTX Topco | 31k | $439k | 100% | Jun 2026 |
|
| Bnp Paribas Arbitrage, Snc | 30k | $424k | 2684% | Jun 2026 |
|
| Raymond James Financial | 25k | $346k | 56% | Jun 2026 |
|
| Sequoia Financial Advisors | 20k | $282k | -67% | Jun 2026 |
|
| Engineers Gate Manager | 15k | $211k | 100% | Jun 2026 |
|
| Citigroup | 14k | $135k | 100% | Sep 2026 |
|
| Laird Norton Tyee Trust | 13k | $182k | 4% | Jun 2026 |
|
| United Bank | 13k | $181k | 100% | Jun 2026 |
|
| Rockefeller Capital Management | 13k | $179k | 0% | Jun 2026 |
|
| T3 Companies | 10k | $96k | 100% | Sep 2026 |
|
| Jpmorgan Chase & Co | 2.9k | $41k | 100% | Jun 2026 |
|
| ORG Wealth Partners | 2.4k | $23k | 100% | Sep 2026 |
|
| GAMMA Investing | 2.3k | $22k | 18% | Sep 2026 |
|
| FNY Investment Advisers | 1.4k | $12k | 100% | Sep 2026 |
|
| Rhumbline Advisers | 1.3k | $18k | -8% | Jun 2026 |
|
| SRS Capital Advisors | 87.00 | $1.2k | 100% | Jun 2026 |
|
| Nuveen | 78.00 | $760.999200 | 100% | Sep 2026 |
|
| Caitong International Asset Management | 25.00 | $240.000000 | 4% | Sep 2026 |
|
| Advisor Group Holdings | 10.00 | $140.000000 | -100% | Jun 2026 |
|
| Hanson McClain Advisors | 1.00 | $15.000000 | 0% | Sep 2026 |
|
Who sold out of Kazia Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Balyasny Asset Management | Mar 2026 | 193k | $1.4M |
| Velan Capital Investment Management | Mar 2026 | 135k | $1.0M |
| Royal Bank of Canada | Mar 2026 | 34k | $255k |
| Qube Research & Technologies | Mar 2026 | 11k | $79k |